What does Lung Ying-tai’s rare criticism of Lai Ching-te reflect?: Global Times editorial
The Lai Ching-te administration, driven by the addiction to "Taiwan independence" and acting in reverse, has caused sustained ...
China Daily18h
Hengrui Pharma makes new breakthrough in lung cancer treatment
A key lung cancer congress held in Europe disclosed that a new breakthrough has been made by Hengrui Pharmaceuticals, a leading innovator in China’s pharmaceutical sector, to help prolong and improve ...
Fierce Biotech5d
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...
pharmaphorum3y
AstraZeneca bags Imfinzi okay in big Chinese lung cancer market
China is a hot spot for lung cancer around the world ... including in a cohort of Chinese patients. An updated analysis of the CASPIAN data showed sustained efficacy for Imfinzi plus chemo ...
Summit Therapeutics: Major Upcoming Ivonescimab Data Catalyst May Not Be All It Seems (Rating Downgrade)
Summit Therapeutics' ivonescimab outperforms Keytruda in Phase 3 lung cancer trials. Crucial Western market approval depends ...
A Potential Challenger For AstraZeneca's Blockbuster Lung Cancer Drug?
AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.
The Star23d
Study: Air pollution fuels lung cancer, especially among non-smokers
One key subtype of lung cancer – adenocarcinoma – has become predominant among women in 185 countries, the authors wrote in the Chinese-funded study. “Air pollution can be considered an ...